# RISK: __Insufficient testing capacity__ (PBN__Risk_740)

## Property: has_RiskGBN

* [No](PBN__RiskGBN_0)

## Property: has_RiskName

Difficulty in identifying and isolating infected individuals, increased risk of undetected transmission

## Property: has_RiskDescription

Inadequate capacity to test individuals for contagious diseases

## Property: has_RiskTechnology

* [diagnostic testing systems](PBN__Technology_1558)
* [point-of-care testing devices](PBN__Technology_1559)

## Property: has_RiskType

* [technological](PBN__RiskType_5)
* [economic](PBN__RiskType_3)
* [political](PBN__RiskType_1)

## Property: has_RiskSubject

* [general population](PBN__Stakeholder_9)
* [healthcare organizations](PBN__Stakeholder_216)
* [government](PBN__Stakeholder_73)

## Property: has_RiskMitigation

* [Pooled-sample analysis](PBN__RiskMitigation_1022)
* [Increase testing capacity, develop rapid and accurate test kits, promote widespread testing](PBN__RiskMitigation_2723)
* [Pooled-sample analysis](PBN__Mitigation_510)

## Property: has_RiskSource

* [silva_covid-abs_2020](PBN__Article_139)

## Property: has_RiskOwner

* [government](PBN__Stakeholder_73)
* [healthcare organizations](PBN__Stakeholder_216)
* [diagnostic test manufacturers](PBN__Stakeholder_1392)

## Property: has_RiskISO_Impact

* [Living and working environment](PBN__RiskISO_Purpose_1)

## Property: has_RiskISO_Purpose

* [Resilience](PBN__RiskISO_Impact_2)

## Property: has_RiskHealth

* [physical](PBN__RiskHealth_0)

